Better Therapeutics (Better Therapeutics) YoY EPS Growth : 68.75% (As of Sep. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Better Therapeutics YoY EPS Growth?

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months. Better Therapeutics's YoY EPS Growth for the quarter that ended in Sep. 2023 was 68.75%.

Better Therapeutics's Earnings per Share (Diluted) for the three months ended in Sep. 2023 was $-0.15.

Better Therapeutics YoY EPS Growth Historical Data

The historical data trend for Better Therapeutics's YoY EPS Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Better Therapeutics YoY EPS Growth Chart

Better Therapeutics Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

YoY EPS Growth

-9.87

-831.14

45.66

Better Therapeutics Quarterly Data
	Dec19	Jun20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
YoY EPS Growth	Get a 7-Day Free Trial									11.93	47.89	4.88	42.86	68.75

Better Therapeutics YoY EPS Growth Calculation

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months.

Better Therapeutics's YoY EPS Growth for the fiscal year that ended in Dec. 2022 is calculated as:

	YoY EPS Growth (A: Dec. 2022 )
=	(Earnings per Share (Diluted) (A: Dec. 2022 )	-	Earnings per Share (Diluted) (A: Dec. 2021 ))	/	\| Earnings per Share (Diluted) (A: Dec. 2021 ) \|
=	(-1.69	-	-3.11)	/	\| -3.11 \|
=	45.66 %

Better Therapeutics's YoY EPS Growth for the quarter that ended in Sep. 2023 is calculated as:

	YoY EPS Growth (Q: Sep. 2023 )
=	(Earnings per Share (Diluted) (Q: Sep. 2023 )	-	Earnings per Share (Diluted) (Q: Sep. 2022 ))	/	\| Earnings per Share (Diluted) (Q: Sep. 2022 )) \|
=	(-0.15	-	-0.48)	/	\| -0.48 \|
=	68.75 %

Better Therapeutics YoY EPS Growth Related Terms

Thank you for viewing the detailed overview of Better Therapeutics's YoY EPS Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Better Therapeutics (Better Therapeutics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Better Therapeutics Inc (OTCPK:BTTX) » Definitions » YoY EPS Growth

Comparable Companies

Traded in Other Exchanges

N/A

Address

548 Market Street, Suite 49404, San Francisco, CA, USA, 94104

Website

https://www.bettertx.com

Better Therapeutics Inc is a prescription digital therapeutics company developing a novel form of cognitive behavioural therapy to address the root causes of cardiometabolic diseases. The company has developed a proprietary platform for the development of FDA-regulated, software-based solutions for type 2 diabetes, heart disease and other conditions.

Executives

Elder Granger	director	5176 S. LEWISTON WAY, CENTENNIAL CO 80015
Mark A. Berman	officer: Chief Medical Officer	548 MARKET STREET, #49404, SAN FRANCISCO CA 94104
Geoffrey M. Parker	director	15 RIORDAN PLACE, MENLO PARK CA 94025
Frank Karbe	director, officer: See Remarks	C/O MYOVANT SCIENCES INC., 2000 SIERRA POINT PARKWAY, 9TH FLOOR, BRISBANE CA 94005
David P Perry	director, 10 percent owner, officer: See Remarks	1020 EAST MEADOW CIRCLE, PALO ALTO CA 94303
Andrew J. Armanino	director	C/O CALIFORNIA BANCORP, 1300 CLAY STREET, FIFTH FLOOR, OAKLAND CA 94612
Georgianna Maule-ffinch 2015 Trust	10 percent owner	C/O BETTER THERAPEUTICS, INC., 548 MARKET STREET, #49404, SAN FRANCISCO CA 94104
Mark Heinen	officer: See Remarks	548 MARKET STREET, #49404, SAN FRANCISCO CA 94104
Risa J Lavizzo-mourey	director	GE HEALTHCARE TECHNOLOGIES INC., 500 W. MONROE ST., CHICAGO IL 60661
Kevin J Appelbaum	director, 10 percent owner, officer: Chief Executive Officer	4160 DUBLIN BLVD., SUITE 200, DUBLIN CA 94568
Suying Liu	director	311 WEST 43RD STREET, 12TH FLOOR, NEW YORK NY 10036
Justin Zamirowski	officer: Chief Commercial Officer	548 MARKET STREET, #49404, SAN FRANCISCO CA 94104
Kristin Wynholds	officer: Chief Product Officer	548 MARKET STREET, #49404, SAN FRANCISCO CA 94104
Richard H Carmona	director	1221 BROADWAY, OAKLAND CA 94612
David P. Perry 2015 Trust	10 percent owner	548 MARKET STREET, #49404, SAN FRANCISCO CA 94104